Literature DB >> 24392833

N-acetylcysteine alleviated silica-induced lung fibrosis in rats by down-regulation of ROS and mitochondrial apoptosis signaling.

Lin Zhang1, Yan-Ling He, Qing-Zhao Li, Xiao-Hui Hao, Zuo-Feng Zhang, Ju-Xiang Yuan, Yu-Ping Bai, Yu-Lan Jin, Nan Liu, Gang Chen, Xiang Yun, San-Qiao Yao.   

Abstract

Reactive oxygen species (ROS) is a normal metabolic product of cellular respiration, but too much ROS can induce cell apoptosis. Here, we used N-acetylcysteine (NAC) to inhibit ROS activity to explore the effects of NAC on silica-induced pulmonary fibrosis in rats and provide evidence for study on the mechanism of silicosis. 24 adult male Sprague-Dawley rats weighing 180-220 g were randomly divided into three groups with eight rats in each group. Silicosis model group and NAC group were adopted non-tracheal exposure method of disposable intrapulmonary injection of 50 g/L, silica suspension 1 mL to establish animal silicosis model, NAC group treated with 600 mg/kg NAC by gavage from the right day of modeling, all animals were sacrificed after 28 days. The level of ROS contents and mitochondrial transmembrane potential changes of AM, the mRNA expression level of type I and type III procollagen, cytochrome C, cysteinyl aspartate specific protease-9 and caspase-3 were detected. The severity of pathological changes and pulmonary fibrosis were observed by pathologic specimens. It was showed that ROS contents and MTP changes were lower in the NAC group compared with the silicosis model group, other indexes were lower in the NAC group than the model group, but higher than those of the control group, the degree of lung fibrotic lesions observed from the pathological slices showed the same trend. These data indicated that NAC can reduce ROS content of AM in silica exposure rats, the mitochondrial apoptosis pathway can also be inhibited, the severity of pulmonary fibrosis alleviated as a result.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24392833     DOI: 10.3109/15376516.2013.879974

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  13 in total

1.  Earthworm extract attenuates silica-induced pulmonary fibrosis through Nrf2-dependent mechanisms.

Authors:  Jingjin Yang; Ting Wang; Yan Li; Wenxi Yao; Xiaoming Ji; Qiuyun Wu; Lei Han; Ruhui Han; Weiwen Yan; Jiali Yuan; Chunhui Ni
Journal:  Lab Invest       Date:  2016-10-24       Impact factor: 5.662

2.  N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys.

Authors:  Yang Shen; Nai-Jun Miao; Jin-Lan Xu; Xin-Xin Gan; Dan Xu; Li Zhou; Hong Xue; Wei Zhang; Li-Min Lu
Journal:  Acta Pharmacol Sin       Date:  2016-04-04       Impact factor: 6.150

3.  Dioscin Alleviates Crystalline Silica-Induced Pulmonary Inflammation and Fibrosis through Promoting Alveolar Macrophage Autophagy.

Authors:  Sitong Du; Chao Li; Yiping Lu; Xue Lei; Yiting Zhang; Siyi Li; Fangwei Liu; Ying Chen; Dong Weng; Jie Chen
Journal:  Theranostics       Date:  2019-03-07       Impact factor: 11.556

4.  Clinical efficacy of acetylcysteine combined with tetrandrine tablets in the treatment of silicosis and the effect on serum IL-6 and TNF-α.

Authors:  Jianling Sun; Pingping Song; Yan Wang; Yanxia Chen
Journal:  Exp Ther Med       Date:  2019-08-30       Impact factor: 2.447

5.  N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis.

Authors:  Huaping Huang; Mingjing Chen; Feng Liu; Haifeng Wu; Jie Wang; Jialiang Chen; Meihua Liu; Xi Li
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

Review 6.  Cell-Based Therapy for Silicosis.

Authors:  Miquéias Lopes-Pacheco; Elga Bandeira; Marcelo M Morales
Journal:  Stem Cells Int       Date:  2016-03-15       Impact factor: 5.443

Review 7.  Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine.

Authors:  Marjukka Myllärniemi; Riitta Kaarteenaho
Journal:  Eur Clin Respir J       Date:  2015-02-10

8.  Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia.

Authors:  Sujit Suklabaidya; Biswajit Das; Syed Azmal Ali; Sumeet Jain; Sharada Swaminathan; Ashok K Mohanty; Susen K Panda; Pujarini Dash; Subhankar Chakraborty; Surinder K Batra; Shantibhusan Senapati
Journal:  Oncotarget       Date:  2016-07-05

Review 9.  Drugs and Targets in Fibrosis.

Authors:  Xiaoyi Li; Lixin Zhu; Beibei Wang; Meifei Yuan; Ruixin Zhu
Journal:  Front Pharmacol       Date:  2017-11-23       Impact factor: 5.810

10.  Long non-coding RNA deep sequencing reveals the role of macrophage in liver disorders.

Authors:  Zhang Lin; Hao Changfu; Zhao Fengling; Guo Wei; Bao Lei; Li Yiping; Zhang Miao; Yue Zhongzheng; Zhao Youliang; Duan Shuyin; Yao Wu
Journal:  Oncotarget       Date:  2017-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.